Bridging preclinical discovery and clinical development – turning ocular research into therapeutic progress

Experimentica is an ocular CRO providing preclinical models and services to pharmaceutical, biotech, and academic clients in ophthalmic research and drug development. Since 2013, we have built a global presence with customers across North America, Europe, and Asia-Pacific. Combining advanced platforms and strong R&D expertise, we develop ocular models that answer key questions on mechanisms of action, efficacy, safety, biomarkers, and readouts. With the establishment of a GLP-compliant test facility, Experimentica is expanding its capabilities in GLP safety and toxicology studies. This strengthens our support for ophthalmic drug development from exploratory preclinical research toward clinical development.